/Investor DB

Wellington Management

Institutional investoroperating company · company profile

Boston · Growth–Late Stage · 41 people tracked

Also known as WELLINGTON ALTERNATIVE INVESTMENTS LLC · WELLINGTON FUNDS (US) LLC · Wellington Investment · WELLINGTON MANAGEMENT COMPANY LLP · WELLINGTON MANAGEMENT HONG KONG LIMITED · WELLINGTON MANAGEMENT JAPAN PTE. LTD.

Find your way into Wellington Management

Sign up to see every warm intro you have to Wellington Management

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Wellington Management team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Wellington's alternative investments platform draws on the firm's research depth, specialized teams, and scale to build solutions across liquid alternatives, hedge funds, and private investing. Its liquid alternatives and hedge fund efforts, backed by 30 years of experience, cover long/short equity, macro, multi-strategy, long/short credit, and relative value. The Private Investing teams deliver differentiated solutions across sectors, combining backgrounds as entrepreneurs, investors, and scientists with insights from public market experts to capture value across all company growth stages, including late-stage growth equity and private biotech. The platform serves institutional and professional investors seeking diversification and return opportunities across public and private markets.

Source: firm website, verified Sep 29, 2026.

Stage
Growth–Late Stage
Check
$5M – $50M
HQ
Boston, Massachusetts, US
Leads rounds
Follows
Instruments
Equity · Debt
Founded
1928
Last 12 months
22 investments
AUM
$5.4B
Tracked investments
249
Unicorns
58
IPOs
43
Acquisitions
17

Team · 41 people

from the firm's website & curated & public directories
John Norberg· Enterprise Risk Managementin

Leads enterprise risk management at the firm.

Samantha Schoen· Next Head of the Client Platformin

Named as the next Head of the Client Platform, succeeding Steve Klar.

Andrew Heiskellin

6 people who came through Wellington Management went on to found or lead other companies.

What they invest in

from 222 of 249 portfolio companies

Biotech ×76Healthtech ×70SaaS ×54AI & Machine Learning ×50Enterprise Software ×47Fintech ×36Medical Devices ×34Consumer ×22

HQs:United States×172United Kingdom×7India×5Brazil×2Canada×2China×2

Who they back

founder profiles across 133 portfolio companies
26%
solo founders
35 of 133 mapped founding teams
44%
repeat founders
of 158 founders with career history
~4 yrs
old at investment
median across 56 dated deals

Founding team size:solo founder×352 founders×453 founders×194+ founders×34

Where their founders studiedfrom 142 founders with education data

Harvard Business School ×11Stanford University ×9Harvard University ×7Massachusetts Institute of Technology ×6University of Southern California ×5Yale University ×5Columbia University ×4Stanford University Graduate School of Business ×4

What their founders studiedfrom 132 founders with field-of-study data

Computer Science ×36Engineering ×29Business & Management ×16Life Sciences ×16Economics ×15Finance & Accounting ×7Humanities ×7Chemistry ×6

Where their founders worked beforefrom 158 founders with career history

Google ×14Microsoft ×11McKinsey & Company ×8Twitter ×5Stanford University ×4Atlas Venture ×3Autodesk ×3Bain & Company ×3

Accelerator rootsportfolio companies that came through a program

Y Combinator ×9

30 founders hold a PhD · 28 hold an MBA (of 141 with degree data)

Investments · 249 tracked

founders shown can be your intro path

By year:2026 · 172025 · 152024 · 102023 · 32022 · 82021 · 202020 · 42019 · 52018 · 52017 · 32016 · 42015 · 6108 dated

Affirmaffirm.comin𝕏NASDAQ: AFRM

Affirm provides a point-of-sale financing platform that allows consumers to make purchases and pay over time, available online and in-store through its Affirm Card and browser extension integrations.

ConsumerE-commerceFintechRetail TechSan Francisco, US

Max Levchin(Founder)inNathan Gettings(Founder)Libor Michalek(President)inRobert O'Hare, CFAinAlex Rampell(Founder)Jeff Kaditz(Founder)

Co-investorsAndreessen HorowitzBattery VenturesCaffeinated CapitalClocktower VenturesCraft VenturesFelicis Ventures+19 more

Airbnbairbnb.comin𝕏NASDAQ: ABNB

Airbnb is an online marketplace that enables people to book and list accommodations for short-term rentals, experiences, and services around the world.

ConsumerMarketplacesTravel & HospitalitySan Francisco, US

Brian Chesky(CEO)inNathan Blecharczyk(CTO)inJoe Gebbia(CPO)inBelinda Johnson(Executive Officer)inLaurence Tosi(Chief Financial Officer)inAndrew Swain(Executive Officer)in

Co-investors137 VenturesA.Capital VenturesA*ACME CapitalAglae VenturesAlign Ventures+78 more

Apogee Therapeuticsapogeetherapeutics.cominNASDAQ: APGE

Apogee Therapeutics develops engineered antibody therapies to treat inflammatory and immune diseases with reduced injection frequency compared to existing treatments.

BiotechHealthtechMedical Devices

Michael Henderson(Chief Executive Officer and Director)in

Co-investorsAccess BiotechnologyRA CapitalBlackstone Life SciencesPerceptive Xontogeny VentureRTW Investments L.P.Venrock Healthcare Capital Partners

Avalyn Pharma Incavalynpharma.cominNASDAQ: AVLNSep 2023 · $175M

Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.

BiotechHealthtech

Lyn Baranowski(CEO)in

Co-investorsAndera PartnersCatalio Capital Management, LPF-Prime CapitalInVivium CapitalNorwest Venture PartnersPivotal Life Sciences+9 more

Beta Bionics, Incbetabionics.cominNASDAQ: BBNX

Beta Bionics develops the iLet Bionic Pancreas System, an insulin delivery device for people with type 1 diabetes aged 6 and older that requires a physician's prescription.

Digital HealthHealthtechMedical DevicesIrvine, US

Edward Damiano(Executive Officer, Director)Sean Saint(President, Chief Executive Officer and Director)inStephen Feider(Chief Financial Officer)inMike Mensinger(Chief Product Officer)inSteven Russell(Chief Medical Officer)inMark Hopman(Chief Commercial Officer)in

Co-investorsLifeSci Venture PartnersOmega FundsRTW Investments L.P.Soleus Capital

Black Diamond Therapeutics, Incblackdiamondtherapeutics.comNASDAQ: BDTX

Black Diamond Therapeutics develops small-molecule kinase inhibitors targeting families of oncogenic mutations across cancer types, including its lead candidate silevertinib for EGFR-mutant lung cancer and glioblastoma.

Elizabeth Buck(Chief Scientific Officer)inBrent Hatzis-Schoch(Chief Operating Officer and General Counsel)inSergey Yurasov(Chief Medical Officer)inMelanie Morrison(Chief Development Officer)

Co-investorsLAVLilly Asia VenturesNew Enterprise Associates (NEA)Nextech InvestNSG VenturesRA Capital+4 more

Boundless Bioboundlessbio.comin𝕏NASDAQ: BOLDApr 2021

Boundless Bio develops precision oncology medicines targeting ecDNA-amplified cancers, specifically creating a new category of ecDNA-directed therapies for patients with oncogenic alterations.

BiotechMedical DevicesLa Jolla, US

Zachary D. Hornby(Executive Officer, Director)inRobert Doebele(Chief Medical Officer)inChristian Hassig(Chief Scientific Officer)Jessica Oien(Chief Legal Officer and Corporate Secretary)in

BoardBenjamin Cravatt, Ph.D.(Director)Kristina Burow(Director)in

Co-investorsARCH Venture PartnersNextech InvestRA CapitalAlexandriaCity Hill VenturesSectoral Asset Management+3 more

Coinbasecoinbase.comin𝕏Nasdaq: COIN

Coinbase is a cryptocurrency exchange platform that offers trading, custody, and financial services for cryptocurrencies, stocks, derivatives, and prediction markets to consumers, institutions, and developers.

Crypto & Web3FintechSan Francisco, US

Brian Armstrong(CEO)inFred Ehrsam(Board Of Directors)inEmilie Choi(President & COO)inAlesia Haas(Chief Financial Officer)inPaul Grewal(Chief Legal Officer & Secretary)inLawrence (L.J.) Brock(Chief People Officer)

Co-investors1confirmationA.Capital Venturesa16z cryptoAcrew CapitalAdventure FundAndreessen Horowitz+97 more

Compasscompass.com𝕏NYSE: COMP

Compass is a real estate brokerage that uses technology to help consumers find homes.

B2B MarketplacesEnterprise SoftwareMarketplacesPropTechSaaSManhattan, US

Robert Reffkin(Founder)inOri Allon(Founder)Brad Serwin(Executive Officer)Kalani Reelitz(Executive Officer)Ethan Glass(Executive Officer)inScott Wahlers(Executive Officer)

Co-investors.406 VenturesAdvance Venture PartnersAlpaca VCAlumni VenturesAtomicoCLI Ventures+12 more

Coupangcoupang.comin𝕏NYSE: CPNGDec 2014 · $300M

Coupang operates an online retail platform and logistics network offering same-day and next-day delivery of general merchandise, fresh groceries, and luxury goods; provides restaurant delivery, video streaming, and digital payment services; and operates a marketplace connecting merchants and luxury brands with customers across multiple geographies.

E-commerceFintechLogistics & Supply ChainSeattle, US

Bom Kim(Founder)in

Co-investors137 VenturesCross Creek AdvisorsEntrée CapitalEvolution VC PartnersFJ LabsFounder Collective+16 more

CytomX Therapeuticscytomx.comin𝕏NASDAQ: CTMX

CytomX is a clinical-stage biopharmaceutical company developing conditionally activated biologic cancer therapies, including antibody-based treatments designed to target tumors while limiting effects on healthy tissue.

BiotechHealthtechSouth San Francisco, US

Sean A. McCarthy(Chief Executive Officer and Chairman)inMarcia P. Belvin(SVP, Chief Scientific Officer)inDawn Benson(SVP, Quality and Product Manufacturing)inWayne Chu(Chief Medical Officer)Rachael Lester(SVP, Chief Business Officer)inChris Ogden(Chief Financial Officer)in

Co-investorsATEL VenturesCanaan PartnersLongitude CapitalPfizer Venture InvestmentsOrbiMedThird Rock Ventures

Damora TherapeuticsNASDAQ: DMRANov 2025 · $284.9M

Damora Therapeutics is a preclinical-stage biotechnology company that discovers and develops therapeutic candidates, including DMR-001, DMR-002, and DMR-003, with the goal of advancing treatments through investigational drug applications and clinical trials.

BiotechCopenhagen, US

Garrett Winslow(Executive Officer)inLori Firmani(Executive Officer)inHans T. Schambye(Executive Officer, Director)Jennifer Jarrett(President, Chief Executive Officer and Director)inBecker Hewes(Chief Medical Officer)Sherwin Sattarzadeh(Chief Operating Officer)

Co-investorsAccess BiotechnologyViking GlobalAndreessen HorowitzBAM ElevateBay City CapitalCommodore Capital+8 more

Designtxdesigntx.cominNASDAQ: DSGNJan 2021

Design Therapeutics is a biopharmaceutical company developing small molecule therapeutic candidates for serious genetic diseases through its GeneTAC (Gene Targeted Chimera) platform.

BiotechMedical DevicesSolana Beach, US

Pratik Shah, Ph.D.(Executive Officer, Director)Aseem Z. Ansari, Ph.D.(Director)Sean Jeffries, Ph.D.(Executive Officer)

BoardSimeon George, M.D.(Director)Stella Xu, Ph.D.(Director)Rodney Lappe, Ph.D.(Director)

Co-investorsAvoro Capital AdvisorsQuan CapitalRA CapitalSR One Capital ManagementWestRiver Group

Dyne Therapeuticsdyne-tx.comin𝕏NASDAQ: DYNAug 2020

Dyne Therapeutics develops targeted therapies for genetically driven neuromuscular diseases using its proprietary FORCE platform.

BiotechMedical DevicesWaltham, US

Romesh Subramanian, Ph.D.(Executive Officer)Richard Scalzo(Executive Officer)Joshua Brumm(Executive Officer, Director)Jonathan McNeill, M.D.(Executive Officer)inOxana Beskrovnaya, Ph.D.(Executive Officer)John G. Cox(President and Chief Executive Officer)in

Co-investorsAtlas VentureMPM BioImpactVida VenturesForbionHercules Capital, Inc.RA Capital

Edgewise Therapeuticsedgewisetx.comin𝕏NASDAQ: EWTX

Edgewise Therapeutics discovers and develops small molecule medicines targeting muscle proteins to treat neuromuscular and cardiac diseases, including sevasemten for muscular dystrophies and EDG-7500 for cardiomyopathy, leveraging a proprietary drug discovery platform based on muscle physiology and high-throughput functional assays.

BiotechDigital HealthBoulder, US

Kevin Koch(Executive Officer, Director)inAlan Russell(Director)inBadreddin Edris(Director and Co-Founder)inKenneth Harrison(Director)

BoardPeter Thompson(Director)inJonathan Root(Director)in

Co-investorsBoulder VenturesForesite CapitalOrbiMedUS Venture PartnersViking GlobalDeerfield Management Company+1 more

Entrada Therapeutics, Inc.entradatx.cominNASDAQ: TRDA

Entrada Therapeutics is a biotech company developing intracellular therapeutics based on its proprietary EEV Platform, aimed at reaching previously inaccessible or undruggable disease-causing targets inside cells.

BiotechHealthtechBoston, US

Natarajan Sethuraman(Executive Officer)inNerissa Kreher(Executive Officer)inKory Wentworth(Executive Officer)inDipal Doshi(Chief Executive Officer)inNatarajan Sethuraman, PhD(President of Research and Development)Nathan J. Dowden(President and Chief Operating Officer)in

Co-investors5AM VenturesAgent CapitalMPM BioImpactMRL Ventures FundRoche Venture FundTCG Crossover

HeartFlowheartflow.comin𝕏NASDAQ: HTFL

Heartflow provides an AI-based analysis that converts a coronary CTA scan into a personalized 3D model of the heart, assessing anatomy and physiology to help diagnose and manage coronary artery disease (CAD).

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesRedwood City, US

Christopher K. Zarins(Executive Officer, Director)inCharles A. Taylor(Executive Officer, Director)inNicky Espinosa Hayes(Executive Officer)John Stevens(Executive Officer, Director)inH. Baird Radford, III(Executive Officer)John Farquhar(President, Chief Executive Officer & Director)in

Co-investors3Spoke CapitalBain Capital Life SciencesBlue Venture FundsEmergent Medical Partners, LLPKhosla VenturesLifeforce Capital+3 more

Instil Bioinstilbio.cominNASDAQ: TIL

Instil Bio is a biotechnology company that identifies and acquires or licenses therapeutic candidates for development, with a strategic focus on securing additional novel drug candidates targeting diseases with significant unmet medical needs.

BiotechDallas, US

Bronson Crouch(Chief Executive Officer / Chairman of the Board)inSandeep "Steve" Laumas(Chief Financial Officer & Chief Business Officer)inNimish Shah(Director)inGwen Binder(Director)Neil Gibson(Director)George Matcham(Director)

Co-investorsCurative VenturesVivo CapitalCPMGVenrock

KALA BIOkalarx.cominNASDAQ: KALA

A biopharmaceutical company developing an artificial intelligence infrastructure platform designed for on-premises deployment in biotechnology and pharmaceutical research environments, serving biotech firms and pharma companies seeking secure access to advanced AI capabilities while retaining control over proprietary biological data; the company is also evaluating strategic alternatives for its legacy mesenchymal stem cell secretome assets after discontinuing its lead rare eye disease therapeutic program.

BiotechArlington, US

Justin Hanes(Director)inKevin Pojasek(Executive Officer)inDarius Kharabi(Executive Officer)inTodd Bazemore(Executive Officer)inMark Iwicki(Executive Officer, Director)inMary Reumuth(Executive Officer)in

Co-investorsLongitude CapitalSR One Capital ManagementYsios CapitalAtlas VentureLux CapitalRA Capital+1 more

Klarnaklarna.comNYSE: KLAR

Klarna is a mobile banking and payments platform that offers flexible payment options, shopping features, and financial management tools to millions of users globally through partnerships with thousands of merchants.

ConsumerE-commerceFintechStockholm, SE

Sebastian Siemiatkowski(Founder)inVictor Jacobsson(Founder)inEvgenii Kondratev(Founder)Niklas Adalberth(Founder)Viktor Jacobsson(Founder)

Co-investors1802 Ventures3Spoke CapitalAccess Ventures (New York)Adit Ventures Management, LlcAliya Capital PartnersAlpha Wave Global+59 more

Kymera Therapeuticskymeratx.comin𝕏NASDAQ: KYMR

Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins.

BiotechDeep TechHealthtech

Nello Mainolfi(Founder)inBruce Booth(Chair)in

Co-investorsAtlas VentureAvoro Capital AdvisorsBain Capital Life SciencesBessemer Venture PartnersHatteras Venture PartnersMRL Ventures Fund+7 more

Ncinoncino.cominNASDAQ: NCNO

nCino provides a cloud-based, AI-powered banking platform with role-based AI agents that support commercial, consumer, small business, and mortgage lending, account opening, and portfolio and operations analytics.

AI & Machine LearningFintechSaaSWilmington, US

Pierre Naude(Founder)inNeil Underwood(Director)inNathan Snell(Director of Software Development)inJonathan Rowe(Director of Marketing)inTom DiVittorio(Head of Product Management and Engineering)inSean Desmond(Head of Professional Services)in

Co-investorsBessemer Venture PartnersInsight PartnersSalesforce VenturesUS Venture Partners

nLight Photonicsnlight.netinNASDAQ: LASR

nLIGHT designs and manufactures high-power semiconductor lasers for defense systems, directed energy applications, and advanced manufacturing.

Deep TechDefense TechHardwareVancouver, US

Scott Keeney(Founder)inJake Bell(Executive Officer)David Schaezler(Executive Officer)inRob Martinsen(Executive Officer)inJoseph DeBartolo(Executive Officer)

BoardBill Ericson(Director)

Co-investorsBonaventure CapitalCarbide VenturesMenlo VenturesMultiplier CapitalOak Investment PartnersMohr Davidow Ventures

Olema Pharmaceuticalsolema.comin𝕏NASDAQ: OLMA

Olema is a clinical-stage biopharmaceutical company developing novel therapies for metastatic breast cancer and other endocrine-driven cancers, targeting nuclear receptors and mechanisms of acquired resistance.

BiotechHealthtechSan Francisco, US

Cyrus L. Harmon, Ph.D.(Director)Cyrus L. Harmon(Director)inDavid C. Myles, Ph.D.(Executive Officer)Sean Bohen, M.D., Ph.D.(Executive Officer, Director)Naseem Zojwalla, M.D.(Executive Officer)inShane Kovacs(Executive Officer)in

Co-investorsAvoro Capital AdvisorsBain Capital Life SciencesForesite CapitalLightspeed Venture PartnersRA CapitalBiotechnology Value Fund+2 more

Omada Healthomadahealth.comin𝕏NASDAQ: OMDA

Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.

Digital HealthHealthtechWellness & FitnessSan Francisco, US

Andrew DiMichelle(Executive Officer, Director)Adrian James(Founder)inSean Duffy(Founder)inWei-Li Shao(President)inSteve Cook(Chief Financial Officer)inAndrew DiMichele(Founder)

Co-investorsaMoonAndreessen HorowitzBlackbird VenturesCanvas VenturesCivilization Ventures Management, LlcDesigner Fund+18 more

Oscar Healthhioscar.com𝕏NYSE: OSCR

Oscar Health is a healthcare technology company that builds and operates a health insurance platform, offering individual, small group, and Medicare Advantage plans to members across the United States.

Digital HealthHealthtechInsurTechNew York, US

Mario Schlosser(Founder)inJoshua Kushner(Founder)Mark T. Bertolini(Chief Executive Officer)inJosh Kushner(Founder)Kevin Nazemi(Founder)

Co-investors8VCA-Rod CorpBoxGroupBreyer CapitalCapitalGCoatue Management+22 more

PagerDutypagerduty.comin𝕏NYSE: PDAug 2018

PagerDuty provides a platform for incident response and operations management that enables teams across technical and business functions to respond to critical events in real time.

AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Alex Solomon(CTO)inDan Alexandru Solomon(Director)Jennifer Tejada(Executive Chair)inSteven Gatoff(Executive Officer)inJohn DiLullo(Chief Executive Officer)inBaskar Puvanathasan(Software Engineer / Product Manager)

Co-investorsAccelAndreessen HorowitzAurumBaseline VenturesBessemer Venture PartnersBling Capital+17 more

Pelotononepeloton.comNASDAQ: PTONAug 2018 · $550M

Peloton develops connected fitness equipment and a digital fitness app that delivers personalized workout classes and training guidance to home exercisers.

ConsumerHardwareWellness & FitnessNew York, US

Graham Stanton(Founder)John Foley(Founder)inHisao Kushi(Founder)inPeter Stern(Chief Executive Officer and President)inElizabeth Coddington(Chief Financial Officer)Nick Caldwell(Chief Product Officer)in

Co-investorsAnsa CapitalBlue CollectiveBullishCade VenturesCoatue ManagementFELIX CAPITAL+22 more

Pinterestpinterest.cominNYSE: PINS

Pinterest operates a visual discovery platform where users save and browse images organised into boards, used heavily for shopping, recipes and design.

San Francisco, US

Evan Sharp(Founder)Ben Silbermann(Founder)inPaul Sciarra(Founder)Mike Yang(Executive Officer)Natalie Fair(Executive Officer)inBill Ready(Chief Executive Officer)in

Co-investors3Spoke CapitalA.Capital VenturesA*Acequia Capital (AceCap)Allied Venture PartnersAmakor+64 more

Prothenaprothena.comin𝕏NASDAQ: PRTAMar 2018

Prothena is a clinical-stage biotechnology company developing investigational therapies for neurodegenerative and rare peripheral amyloid diseases by targeting misfolded proteins.

BiotechDun Laoghaire, Co. Dublin, US

Tran B. Nguyen(Executive Officer)Arthur W. Homan(Executive Officer)Karin L. Walker(Executive Officer)inTara Nickerson, Ph.D.(Executive Officer)Wagner M. Zago, Ph.D.(Executive Officer)Carol D. Karp(Executive Officer)in

Co-investorsSofinnova VenturesInvescoRA Capital

Pure Storagepurestorage.comin𝕏NYSE: PSTGApr 2014

Pure Storage provides data storage infrastructure that unifies data into a single virtual cloud of storage with automated, policy-driven management.

Cloud ComputingData & InfrastructureEnterprise SoftwareSanta Clara, US

Mike Speiser(Founding CEO, Investor & Board Member (Sutter Hill Ventures incubation))inJohn Colgrove(Founder)inJohn Hayes(Founder)inTarek A. Robbiati(Chief Financial Officer)inPatrick Finn(Chief Revenue Officer)Ajay Singh(Chief Product Officer)in

Co-investorsDag VenturesGlynn Capital ManagementGreylock PartnersIn-Q-TelIndex VenturesIVP (Institutional Venture Partners)+7 more

Scribe Therapeuticsscribetx.comin𝕏NASDAQ: SCTXMar 2021

Scribe is a molecular engineering company developing CRISPR-based genetic therapies to treat cardiometabolic disease and other conditions.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

Benjamin Oakes(Founder)inJennifer A. Doudna, PhD(Co-founder, Scientific Advisor)Benjamin L. Oakes, PhD(Co-founder, President and CEO)David F. Savage, PhD(Co-founder, Scientific Advisor)Brett Staahl, PhD(Co-founder, VP of External Innovation)Brett Staahl(Founder)

Co-investorsAndreessen HorowitzOrbiMedAvoro Capital AdvisorsMenlo VenturesRA Capital

Spotifyspotify.cominNYSE: SPOT

Spotify operates an audio streaming platform offering music, podcasts and audiobooks through free ad-supported and paid subscription tiers.

ConsumerMedia & EntertainmentStockholm, SE

Martin Lorentzon(Founder)Daniel Ek(Founder)inBarry McCarthy(Director)inGustav Söderström(Co-Chief Executive Officer)inAlex Norström(Co-Chief Executive Officer)inChristian Luiga(Chief Financial Officer)in

Co-investors137 VenturesBreyer CapitalCoatue ManagementFJ LabsFounders FundGreen Sands Equity+15 more

Sprinklr, Inc.sprinklr.comin𝕏NYSE: CXMApr 2014

Sprinklr provides an AI-native customer experience platform that manages feedback, customer interactions, and contact center operations across multiple channels.

AI & Machine LearningEnterprise SoftwareMarketing TechSaaSNew York, US

Ragy Thomas(Founder)inMurali Swaminathan(Executive Officer, Director)inChristopher Lynch(Executive Officer)Carlos Dominguez(Director)inRory Read(President and Chief Executive Officer)in

BoardCarey Lai(Director)in

Co-investorsAzure Capital PartnersBattery VenturesConductive VenturesHellman & FriedmanICONIQJC2 Ventures+8 more

TherapeuticsMDtherapeuticsmd.cominNASDAQ: TXMD

TherapeuticsMD is a royalty company that licenses its women's health products to exclusive licensing partners in the United States and internationally.

BiotechFemTechHealthtechBoca Raton, US

Robert G. Finizio(Executive Officer, Director)inMichael Donegan(Executive Officer)inJohn C.K. Milligan, IV(Executive Officer)Edward Borkowski(Executive Officer)inJames C. D'Arecca(Executive Officer)inMarlan D. Walker(Chief Executive Officer)

Uberuber.comin𝕏NYSE: UBER

Uber operates a multi-sided platform providing ride-sharing, food delivery, freight logistics, and business fleet management services across various global markets.

Logistics & Supply ChainMarketplacesMobility & TransportationSan Francisco, US

Travis Kalanick(Founder)Garrett Camp(Founder)inGautam Gupta(Executive Officer)inJeffrey Holden(Executive Officer)David Plouffe(Executive Officer)inEmil Michael(Executive Officer)in

Co-investors137 Ventures3Spoke Capital408 VenturesA*ACME CapitalAcross Capital Partners+91 more

Upstream Bioupstreambio.comin𝕏NASDAQ: UPB

Upstream Bio is a biotechnology company that sponsors clinical trials to develop products under investigation.

BiotechHealthtechWaltham, US

Rand Sutherland(Chief Executive Officer)inAllison Ambrose(General Counsel)inAaron Deykin(Chief Medical Officer & Head of R&D)inMike Gray(Chief Financial Officer and Chief Operating Officer)Adam Houghton(Chief Business Officer)inStacy Price(Chief Technology Officer)in

Co-investorsOrbiMedAccess IndustriesAccess BiotechnologyBain Capital Life SciencesDecheng CapitalHBM Healthcare Investments+5 more

Voyager Therapeutics, Inc.voyagertherapeutics.comNASDAQ: VYGR

Voyager Therapeutics is a biotechnology company developing genetic medicines for neurological diseases of the central nervous system, including Alzheimer's disease, ALS, and Parkinson's disease.

BiotechHealthtechLexington, US

Todd Carter(Executive Officer)inRobin Swartz(Executive Officer)inAlfred Sandrock(Executive Officer, Director)Peter Pfreundschuh(Executive Officer)inNathan Jorgensen(Chief Financial Officer; Principal Financial Officer and Principal Accounting Officer)Steven Hyman(Director)

Co-investorsARCH Venture PartnersFidelity InvestmentsThird Rock Ventures

Zenas Biopharmazenasbio.cominNASDAQ: ZBIO

Zenas BioPharma is a biopharmaceutical company developing therapies for autoimmune diseases, with two late-stage drug candidates: obexelimab, a bifunctional monoclonal antibody targeting CD19 and FcγRIIb to suppress B cell activity, and orelabrutinib, an oral BTK inhibitor.

BiotechHealthtechWaltham, US

LEON O. MOULDER, JR.(Director)Lonnie Moulder(Founder)JOSEPH FARMER(Executive Officer)HUA MU(Executive Officer, Director)in

BoardPATRICK GERALD ENRIGHT(Director)inHONGBO LU(Director)

Co-investorsDelos CapitalLongitude CapitalNew Enterprise Associates (NEA)Norwest Venture PartnersPivotal Life SciencesQuan Capital+3 more

Ziprecruiterziprecruiter.comNYSE: ZIPAug 2014

ZipRecruiter operates an online marketplace that matches job seekers with employers using AI-powered algorithms to identify qualified candidates and relevant positions.

Santa Monica, US

Willis Redd(Director)inWard Poulos(Director)Joe Edmonds(Executive Officer, Director)Ian Siegel(Executive Officer, Director)in

BoardEric Liaw(Director)in

Co-investorsIVP (Institutional Venture Partners)

54Gene54gene.comin𝕏Series ADefunct

54Gene conducts genomics research and provides related services to increase the representation of African genetic data in medical research, which aims to advance healthcare solutions globally.

HealthtechWellness & FitnessLagos, NG

Gatumi Aliyu(Founder)inAbasi Ene-Obong(CEO)inOgochukwu Francis Osifo(Founder)inDamilola Oni

Co-investorsAdjuvant CapitalBVP InvestorsEndeavor CatalystFifty YearsFuture AfricaKairos Angels+16 more

Abnormal Aiabnormal.aiin𝕏Apr 2018

Abnormal is an AI-native cybersecurity company that uses behavioral AI to detect and prevent email-based attacks and anomalous threats.

AI & Machine LearningCybersecurityEnterprise SoftwareSan Francisco, US

Evan Reiser(Founder)inSanjay Jeyakumar(Founder)inRami Habal(Chief Product Officer (former))inSmita Sanadhya(Chief Financial Officer (former))inJeff True(Chief Legal Officer (former))inAbhi Bagri(Chief Technology Officer)in

Co-investorsAlkeon InnovationArtisanal VenturesBallistic VenturesEQUIAMGreylock PartnersInflection Ventures+4 more

Acrivon Therapeuticsacrivon.com

Acrivon is a clinical-stage oncology company developing precision medicine therapeutics for cancer treatment, using its proprietary AP3 proteomics platform to create companion diagnostics that match patients to drugs based on tumor-driving mechanisms.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

Peter Blume-Jensen(Executive Officer, Director)Kristina Masson(Executive Officer, Director)erick gamelininEric Devroe(Executive Officer)in

BoardMarcin Czernik(Director)Sharon Shacham(Director)

Co-investorsNew Enterprise Associates (NEA)Pureos BioventuresRA Capital

ACVacvauctions.comin𝕏

ACV Auctions operates an automotive marketplace and product suite that enables business partners in the used vehicle industry to manage their operations and transactions.

E-commerceLogistics & Supply ChainMarketplacesBuffalo, US

Joseph S. Neiman(Executive Officer, Director, Promoter)John Louis Greco(Executive Officer, Director)Daniel K. Magnuszewski(Executive Officer, Director)George Chamoun(Founder)inDan Magnuszewski(Founder)Jack Greco(Founder)

Co-investorsAkkadian VenturesArmory Square VenturesBain Capital VenturesBessemer Venture PartnersHomebrewTribeca Venture Partners+1 more

Agilonhealthagilonhealth.com

agilon health partners with community-based primary-care physician groups, providing capital, data, payor relationships, and operational support so they can take on total-care risk for Medicare patients under a value-based model.

Digital HealthHealthtechSaaS

Aligos Therapeuticsaligos.comin𝕏

Aligos is a clinical-stage biotechnology company developing therapeutics for liver and viral diseases, including chronic hepatitis B virus (HBV) infection and MASLD/MASH.

BiotechHealthtechSouth San Francisco, US

Leonid Beigelman(President)inLawrence M. Blatt(Chairman, President & CEO (Co-founder))inHardean Achneck(Executive Officer)inBrian Dowd(Executive Vice President - Controller)inLucinda Quan(Executive Vice President - General Counsel)inJulian Symons(Executive Vice President, Chief Scientific Officer)in

Co-investorsPivotal Life SciencesRoche Venture FundVivo Capital

Alkeuspharmaalkeuspharma.comin𝕏

Alkeus Pharma develops therapies for retinal diseases, including inherited and neovascular conditions.

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

Carlos Quezada-Ruiz(Chief Medical Officer)in

Co-investorsBain Capital Life SciencesSofinnova VenturesTCG Crossover

AMP Roboticsamprobotics.comin𝕏Dec 2024

AMP builds AI-powered automated sorting systems for waste recycling infrastructure, enabling material recovery and improving separation purity for recycling facilities globally.

AI & Machine LearningCircular EconomyRoboticsColorado, US

Matanya Horowitz(Founder)inTimothy Stuart(Executive Officer, Director)Justin Ross(Executive Officer)inRobert Norris(Executive Officer)inBeth Dec(Executive Officer)Robert Kreamer(Executive Officer, Director)

Co-investors8VCCollaborative FundComet LabsCongruent VenturesGV (Google Ventures)Prelude Ventures+3 more

Anchorageanchorage.comin𝕏Dec 2021

Anchorage Digital is a global cryptocurrency platform providing institutions with custody, staking, trading, governance, and settlement services, along with security infrastructure.

Crypto & Web3Enterprise SoftwareFintechNew York, US

Diogo Mónica(Founder)inNathan McCauley(Founder)in

Co-investorsAndreessen HorowitzGICa16z cryptoAmplify PartnersBlockchain CapitalDelta Blockchain+28 more

Angitia Bioangitiabio.com

Angitia Bio is a biopharmaceutical company developing therapies for musculoskeletal and related diseases.

Biotech

Co-investorsAscenta CapitalFrazier Life SciencesOrbiMedRA CapitalFrazier

Arcadia Powerarcadia.comin𝕏

Arcadia is an energy intelligence platform that helps businesses manage utility bills, procure energy, and track sustainability through a single interface.

AI & Machine LearningClimate TechEnergyEnterprise SoftwareSaaSWashington, US

Kiran Bhatraju(Founder)inRyan Nesbitt(Executive Officer)

Co-investorsAlumni VenturesBay Bridge Ventures ClimateBlue Ivy VenturesBoxGroupBroadscaleCamber Creek+17 more

Arcus Biosciencesarcusbio.comin𝕏

Arcus Biosciences is a clinical-stage biopharmaceutical company that designs small molecule and monoclonal antibody combination therapies for people with cancer.

BiotechHealthtech

Juan Jaen(Co-founder & President)inTerry Rosen(Co-founder & Chief Executive Officer)inBob Goeltz(Chief Financial Officer)inRichard Markus(Chief Medical Officer)inCarolyn Tang(General Counsel)Yvonne Gehring(SVP, Human Resources)

Co-investorsAisling CapitalDecheng CapitalDroia VenturesEcoR1 CapitalForesite CapitalGV (Google Ventures)+4 more

Artiva Biotherapeuticsartivabio.comin𝕏

Artiva Bio is a clinical-stage biotechnology company developing NK cell-based therapies for autoimmune diseases, designed to be manufactured at scale and delivered in community settings.

BiotechHealthtechMedical DevicesSan Diego, US

Jennifer Bush(Executive Officer)inThomas J. Farrell(Executive Officer)Fred Aslan(Executive Officer, Director)inJason Litten(Executive Officer)inEsther van den Boom(Executive Officer)Peter Flynn(Executive Officer)in

Co-investors5AM VenturesEcoR1 CapitalRA CapitalvenBio PartnersvenBio Global Strategic

Asher Bioasherbio.comin𝕏Series B · Apr 2024 · $55M

Asher Bio develops selective immunotherapy drugs that target specific immune cell types to promote beneficial effects while minimizing toxicity.

BiotechHealthtechMedical DevicesSan Francisco, US

Ivana Djuretic(Founder)inAndy Yeung(Drug discovery)inYik Andy Yeung(Executive Officer, Director, Promoter)

Co-investorsEmles Venture PartnersGoAhead VenturesMission Bay CapitalMission BiocapitalRA CapitalY Combinator+9 more

Asset Watchassetwatch.comin𝕏Mar 2026 · $38M

AssetWatch provides cloud-based asset monitoring software and sensor technology to help manufacturing and industrial facilities prevent unplanned equipment downtime.

Advanced ManufacturingEnterprise SoftwareIoTSaaSWesterville, US

William Zell(Executive Officer, Director)William Ruff(Executive Officer)inRobert Lee(Director)inTad Dritz(VP of Development)inJeff Haskett(COO)inBrian Graham(Executive Officer, Director)in

Co-investorsCerity Partners VenturesG2 Venture PartnersHarmonic Growth PartnersJobsOhio VenturesMonte Carlo CapitalOUP (Osage University Partners)+4 more

Atsenatxatsenatx.comin

Atsena Therapeutics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases that cause vision loss.

BiotechDeep TechMedical DevicesAustin, US

Co-investorsLightstone VenturesHatteras Venture PartnersSofinnova Ventures

Attentive Mobileattentivemobile.comin𝕏

Attentive provides a mobile-first customer engagement platform that enables brands to orchestrate email, SMS, RCS, push, and AI-powered campaigns.

AI & Machine LearningDirect to ConsumerMarketing TechHoboken, US

Andrew Jones(Founder)inBrian Culbertson Long(Executive Officer, Director)Amit Jhawar(Chief Executive Officer)Brian Long(Founder)

BoardScott Friend(Director)in

Co-investorsAliya Capital PartnersBain Capital VenturesCollective LiquidityDisney AcceleratorEQUIAMFounders Circle Capital+17 more

Auris Healthaurishealth.comJan 2019 · $220M

Developer of a surgical robotic system for minimally invasive endoscopy and laparoscopy

Frederic Moll(Founder)

Co-investorsBeast VenturesLux CapitalMithril Capital ManagementPractica CapitalSBI Investment Korea Co. Ltd.Sonder Capital+5 more

Automatticautomattic.comin𝕏

Automattic develops WordPress.com, WooCommerce, Tumblr, Jetpack, and other web tools that enable publishing, commerce, and messaging.

Cloud ComputingCreator EconomyE-commerceMedia & EntertainmentSaaSSan Francisco, US

Matt Mullenweg(Founder)inPaul Sieminski(Executive Officer)inStuart West(Executive Officer)in

BoardToni Schneider(Director)inPhilip Black(Director)inTony Conrad(Director)in

Co-investors1435 CapitalAglae VenturesAkkadian VenturesCameleon InvestICONIQManhattan Venture Partners+7 more

Averetxaveretx.com

Avere Therapeutics is a biotech company developing AVR-001, an oral once-weekly interleukin-23 receptor antagonist (IL-23RA) for chronic inflammatory diseases such as psoriasis, ulcerative colitis, Crohn's disease, and psoriatic arthritis.

Biotech

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Allena PharmaceuticalsAllenapharmaAngitiaAtrecaAtsena TherapeuticsBlueJay TherapeuticsCogent BiosciencesDesign TherapeuticsGoldfinch BioPharmaLianbioMalauzai SoftwareNanigansObsidian Therapeutics

Browse all 249 investments with full details →

▶49 more tracked companies

SaladSaladSaluda MedicalSatsuma PharmaceuticalsScale AIScopely, Inc.SeatGeekSelectenergySiteOne TheraputicsSkimsSlackSnapdocsSomatusSPANSpotOnStationwiseStrata OncologyStripeSundaeSweptSwiggySynthegoTabbyTaniumTAPTAPTemporalTeyaThe Trade DeskThorasThriveworksTrace MachinaTrade RepublicTraversalTricidaTrove RecommerceTS ConductorTubulis GmbHUiPathUnumrxUrban CompanyUSAVantaVentyx BiosciencesVerve TherapeuticsVuoriWeWork CompaniesWishWizZuora

Exits · 60

43 IPOs · 17 acquisitions · showing 45

AffirmNASDAQ: AFRMAirbnbNASDAQ: ABNBApogee TherapeuticsNASDAQ: APGEAvalyn Pharma IncNASDAQ: AVLNBeta Bionics, IncNASDAQ: BBNXBlack Diamond Therapeutics, IncNASDAQ: BDTXBoundless BioNASDAQ: BOLDCoinbaseNasdaq: COINCompassNYSE: COMPCoupangNYSE: CPNGCytomX TherapeuticsNASDAQ: CTMXDamora TherapeuticsNASDAQ: DMRADesigntxNASDAQ: DSGNDyne TherapeuticsNASDAQ: DYNEdgewise TherapeuticsNASDAQ: EWTXEntrada Therapeutics, Inc.NASDAQ: TRDAHeartFlowNASDAQ: HTFLInstil BioNASDAQ: TILKALA BIONASDAQ: KALAKlarnaNYSE: KLARKymera TherapeuticsNASDAQ: KYMRNcinoNASDAQ: NCNOnLight PhotonicsNASDAQ: LASROlema PharmaceuticalsNASDAQ: OLMAOmada HealthNASDAQ: OMDAOscar HealthNYSE: OSCRPagerDutyNYSE: PDPelotonNASDAQ: PTONPinterestNYSE: PINSProthenaNASDAQ: PRTAPure StorageNYSE: PSTGScribe TherapeuticsNASDAQ: SCTXSpotifyNYSE: SPOTSprinklr, Inc.NYSE: CXMTherapeuticsMDNASDAQ: TXMDUberNYSE: UBERUpstream BioNASDAQ: UPBVoyager Therapeutics, Inc.NASDAQ: VYGRZenas BiopharmaNASDAQ: ZBIOZiprecruiterNYSE: ZIPBluejaytxacq. by Mirum PharmaceuticalsForty Seven Incacq. by GileadGlobal Blood Therapeuticsacq. by PfizerMetseraacq. by PfizerPhyndacq. by symplr

Portfolio news

latest coverage across their companies

IPO stake values · per SEC filings

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Prothena7.2%$22.00Oct 2013$33.7M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has Wellington Management made?
Wellington Management has 249 tracked investments, 60 of which have exited, including 35 dated in the last 24 months.
What stage does Wellington Management invest at?
Wellington Management invests at the Growth, Late Stage stages.
What is Wellington Management's typical check size?
Wellington Management typically writes checks of $5M – $50M.
What sectors does Wellington Management focus on?
Wellington Management focuses on AI & Machine Learning, Biotech, Climate Tech, Consumer, Crypto & Web3, Enterprise Software, Fintech, Healthtech, Impact & Social Good, Sector Agnostic.
Where is Wellington Management located?
Wellington Management is headquartered in Boston, US.
Does Wellington Management lead rounds?
Wellington Management typically participates in rounds rather than leading them.
Who does Wellington Management co-invest with?
Wellington Management most often shares deals with RA Capital, New Enterprise Associates (NEA), Khosla Ventures, among 779 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Morgan Stanley on X: "In the newest Hard Lessons, Wellington Management CEO Jean Hynes discusses the pivotal investment calls that defined her career in biotech—one that delivered outsized long-term value, and one that tested her conviction when the stock fell 90% overnight. https://t.co/Qu0DznXC3y"

Jean Hynes · x.com

Wellington Management CEO Jean Hynes: Dig Deep and Hold Your Position

Morgan Stanley · Jean Hynes

Training Grounds: Wellington Management – Jean Hynes (EP.423)

Capital Allocators with Ted Seides · Jean Hynes

More market volatility is good for active management, says Wellington Management CEO Jean Hynes

Jean Hynes · cnbc.com

A Conversation with Wellington Management CEO Jean Hynes

Zoetis · Jean Hynes

Jean Hynes – Inside Wellington Management (Capital Allocators, EP.82)

Capital Allocators with Ted Seides · Jean Hynes

Images

Wellington Management photoWellington Management photoWellington Management photoWellington Management photoWellington Management photoWellington Management photo

Co-investors · 30

Lightspeed Venture Partners

Lightspeed Venture Partners is a global venture capital firm that backs founders from Seed through Series F and beyond, emphasizing deep, immersive partnerships with the companies it invests in.

$1M – $5M
Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

$500K – $15M
IVP (Institutional Venture Partners)

IVP (Institutional Venture Partners) is a venture capital firm that backs high-growth companies, emphasizing partnership and hands-on support to help portfolio companies scale toward market leadership.

$15M – $75M
Accel

Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.

$500K – $100M
Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

$50K – $100M
GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M
CapitalG

CapitalG is Alphabet's independent growth fund, investing capital and operational expertise to help growth-stage consumer and enterprise technology companies scale.

$75M – $100M
BoxGroup

BoxGroup is an early-stage venture capital firm that invests in startups at their earliest stages.

$250K – $1M
DST Global

DST Global is a global internet-focused investment firm that backs fast-growing, high-value internet companies. It does not solicit or accept retail investors.

General Catalyst

General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.

$30M
▶18 more co-investors

NewView CapitalBonfire VenturesCongruent VenturesFlybridge Capital PartnersValor Equity PartnersRRE VenturesFoundryNotion CapitalBreakthrough Energy VenturesNational Grid PartnersAccel-KKRBowery CapitalGSV AccelerationGeneral PartnershipBetaworks Ventures Management, LlcBrainchild HoldingsLightShed VenturesRed Sea Ventures

Firms observed investing alongside Wellington Management, from public investor directories. Shared companies are the overlap with Wellington Management's recorded portfolio.

Similar investors

Featured in lists